The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled
- 26 November 2017
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 31 (3) , 244-257
Abstract
In patients receiving hemodialysis, the provision of safe and effective vascular access using an arteriovenous fistula or graft is regarded as a critical priority by patients and health professionals. Vascular access failure is associated with morbidity and mortality, such that strategies to prevent these outcomes are essential. Inadequate vascular remodeling and neointimal hyperplasia resulting in stenosis and frequently thrombosis are critical to the pathogenesis of access failure. Systemic medical therapies with pleiotropic effects including antiplatelet agents, omega‐3 polyunsaturated fatty acids (fish oils), statins, and inhibitors of the renin‐angiotensin‐aldosterone system (RAAS) may reduce vascular access failure by promoting vascular access maturation and reducing stenosis and thrombosis through antiproliferative, antiaggregatory, anti‐inflammatory and vasodilatory effects. Despite such promise, the results of retrospective analyses and randomized controlled trials of these agents on arteriovenous fistula and graft outcomes have been mixed. This review describes the current understanding of the pathogenesis of arteriovenous fistula and graft failure, the biological effects of antiplatelet agents, fish oil supplementation, RAAS blockers and statins that may be beneficial in improving vascular access survival, results from clinical trials that have investigated the effect of these agents on arteriovenous fistula and graft outcomes, and it explores future therapeutic approaches combining these agents with novel treatment strategies.Keywords
Funding Information
- Royal Australasian College of Physicians
This publication has 102 references indexed in Scilit:
- Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access modelKidney International, 2013
- Arteriovenous Fistula Creation Using the Optiflow Vascular Anastomosis Device: A First in Man Pilot StudySeminars in Dialysis, 2012
- Statin Therapy Is Not Associated with Improved Vascular Access OutcomesClinical Journal of the American Society of Nephrology, 2010
- CKD Accelerates Development of Neointimal Hyperplasia in Arteriovenous FistulasJournal of the American Society of Nephrology, 2009
- Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patientsIndian Journal of Nephrology, 2009
- Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous graftsJournal of Vascular Surgery, 2007
- Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 StudyKidney International, 2005
- Natural history of arteriovenous grafts in hemodialysis patientsAmerican Journal of Kidney Diseases, 2000
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionNew England Journal of Medicine, 1985
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979